Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding

Table 1 Baseline Characteristics of HHT Patient Cohort

Clinical Variables	Reference Range	Mean ± Standard Deviation or n (%)
Race
Caucasian		134 (89.9)
Non-Caucasian		15 (10.1)
Sex
Male		91 (61.1)
Female		58 (38.9)
Age, y		50.6 ± 16.1 (range 18–89)
Epistaxis Severity Score		4.03 ± 2.34
Hemoglobin (Hgb, g dL⁻¹)	13.5–17.5	12.12 ± 2.62^a
Hematocrit (Hct, %)	36–46	37.4 ± 6.76^b
Mean Cell Volume (MCV, fL)	80–100	85.38 ± 8.24^c
Mean Corpuscular Hemoglobin Concentration (MCHC g dL^− 1)	31–37	32.4 ± 1.97^b
Iron (μg dL^− 1)	35–165	63.10 ± 47.8^d
Transferrin (Tfn, mg dL^− 1)	200–380	307.42 ± 54.43^e
Total iron-binding capacity (TIBC μg dL^− 1)	252–479	383.08 ± 69.27^f
Iron saturation (%)	20–50	17.73 ± 15.16^e
Ferritin (ng mL^− 1)	27–377	29.31 ± 49.96^g

ISSN: 1750-1172